Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis
Authors:
Open Access
- 20 July 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (7) , e0133428
Abstract
Long-term inhaled corticosteroids (ICS) may reduce growth velocity and final height of children with asthma. We aimed to evaluate the association between ICS use of >12 months and growth. We initially searched MEDLINE and EMBASE in July 2013, followed by a PubMed search updated to December 2014. We selected RCTs and controlled observational studies of ICS use in patients with asthma. We conducted random effects meta-analysis of mean differences in growth velocity (cm/year) or final height (cm) between groups. Heterogeneity was assessed using the I2 statistic. We found 23 relevant studies (twenty RCTs and three observational studies) after screening 1882 hits. Meta-analysis of 16 RCTs showed that ICS use significantly reduced growth velocity at one year follow-up (mean difference -0.48 cm/year (95% CI -0.66 to -0.29)). There was evidence of a dose-response effect in three RCTs. Final adult height showed a mean reduction of -1.20 cm (95% CI -1.90 cm to -0.50 cm) with budesonide versus placebo in a high quality RCT. Meta-analysis of two lower quality observational studies revealed uncertainty in the association between ICS use and final adult height, pooled mean difference -0.85 cm (95% CI -3.35 to 1.65). Use of ICS for >12 months in children with asthma has a limited impact on annual growth velocity. In ICS users, there is a slight reduction of about a centimeter in final adult height, which when interpreted in the context of average adult height in England (175 cm for men and 161 cm for women), represents a 0.7% reduction compared to non-ICS users.Keywords
This publication has 39 references indexed in Scilit:
- Effect of Inhaled Glucocorticoids in Childhood on Adult HeightNew England Journal of Medicine, 2012
- Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sourcesTherapeutic Advances in Drug Safety, 2011
- A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhalerPediatric Allergy and Immunology, 2010
- Assessment of the Long-term Safety of Inhaled Ciclesonide on Growth in Children With AsthmaPediatrics, 2008
- PrefaceJournal of Allergy and Clinical Immunology, 2007
- Clinical Safety of Inhaled Corticosteroids for Asthma in ChildrenDrug Safety, 2006
- Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC StudyPediatrics, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Low‐dose inhaled budesonide once or twice daily for 27 months in children with mild asthmaAllergy, 2000
- Growth in asthmatic children treated with fluticasone propionateThe Journal of Pediatrics, 1998